Showing results (11-20 of 131) with videos related to
Sort By:
Pageof 14
Current Drug Targets|May 18, 2020
Targeting Enteric Neurons and Plexitis for the Management of Inflammatory Bowel DiseaseRhian Stavely, Raquel Abalo, Kulmira NurgaliExpert Review of Gastroenterology & Hepatology|July 30, 2025
Reviewing novel findings and advances in diagnoses and treatment of primary biliary cholangitisAnnarosa Floreani, Daniela Gabbia, Sara De MartinBiomedicines|July 2, 2021
The Role of Oxidative Stress in NAFLD-NASH-HCC Transition-Focus on NADPH OxidasesDaniela Gabbia, Luana Cannella, Sara De MartinLife (Basel, Switzerland)|April 27, 2024
Are Gender Differences Important for Autoimmune Liver Diseases?Annarosa Floreani, Daniela Gabbia, Sara De MartinNeurogastroenterology and Motility|December 9, 2024
Chemotherapy-Induced Neuropathy Affecting the Gastrointestinal TractGema Vera, Kulmira Nurgali, Raquel AbaloMedical Cannabis and Cannabinoids|November 3, 2023
Neuro-Gastro-Cannabinology: A Novel Paradigm for Regulating Mood and Digestive HealthFabio Turco, Viola Brugnatelli, Raquel AbaloBiomedicines|October 27, 2022
Obeticholic Acid for Primary Biliary CholangitisAnnarosa Floreani, Daniela Gabbia, Sara De MartinExpert Opinion on Investigational Drugs|October 13, 2025
An update on novel investigational agents for the treatment of primary biliary cholangitisAnnarosa Floreani, Daniela Gabbia, Sara De MartinExpert Review of Gastroenterology & Hepatology|July 29, 2023
Primary biliary cholangitis: primary autoimmune disease or primary secretory defectAnnarosa Floreani, Daniela Gabbia, Sara De MartinBiomedicines|July 26, 2020
Depression and Cognitive Impairment-Extrahepatic Manifestations of NAFLD and NASHMartina Colognesi, Daniela Gabbia, Sara De MartinPageof 14